SIADH: Syndrome of inappropriate anti-duiretic hormone, results in excessive anti-duiretic hormone causing excessive fluid retention- euvolaemia & hyponatraemia
Presentation: symptomatic hyponatreaemia (confusion, headaches, drowsiness) with euvolaemic fluid status
Diagnosis: low serum Na+ and osmolality, high urine sodium & osmolality
Management: fluid restriction, address underlying cause
SIADH is caused by excessive ADH production, causing fluid retention and a dilutional hyponatraemia
Clinically, it is hydrated individual who is unable to concentrate their urine, i.e. an inappropriately low urine osmolality in the context of low sodium
History
Asymptomatic
Symptomatic hyponatraemia- confusion, seizures, coma
Symptoms from cause- cough/ weight loss (lung ca), new drug introduction
Examination
Euvolaemia
Investigations
Hyponatraemia & low serum osmolality
Urine: osmolality < serum osmolality
Hyponatraemia work up- TFTs, consider cortisol, calcium, blood glucose
Diagnostic criteria: (3/3)
Hyponatraemia,
Euvolaemia,
Urine osmolality lower than serum
Classification (aetiology):
Malignancy:
Small cell lung cancer (most common)
Rarer: carcinoid, pancreatic, prostate, lymphoma, leukaemia
Drugs (in order of MCQ):
Carbamazepine
Thiazide diuretics (particularly in elderly),
Cyclophosphamide,
Vincristine,
Intracranial lesions & infections
Acute (hyponatraemia)
Fluid restriction 1.5-1.2L
Regular weights
Investigate underlying cause- (cancer): CXR, CT-T/ CTCAP, CT-H
Regular Na+ monitoring (6hrly -24hrly depending upon severity)
Hypertonic saline if seizures/ GCS < 8
Admission if Na < 126 or symptomatic
Stop drug causes
Inpatient reviews
Monitor Na+, weight and urine/ serum osmolality
Monitor symptoms- e.g. confusion
FU underlying cause investigations
Discharge once symptoms and Na+ stable & above 126
Chronic
Fluid restriction as able 1.5-1.2L
Monitor Na+ and weight
Consider goals of care & escalation status
Written in 2024